• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[环孢素治疗大疱性类天疱疮:初步研究]

[Cyclosporin in the treatment of bullous pemphigoid: preliminary study].

作者信息

Barthélémy H, Thivolet J, Cambazard F, Bendelac A, Mauduit G, Granier F, Frappaz A

出版信息

Ann Dermatol Venereol. 1986;113(4):309-13.

PMID:3532906
Abstract

Bullous pemphigoid is a typical autoimmune disease. It is classically treated with systemic corticosteroids alone or combined with immunosuppressants. Cyclosporine A (CyA), a new immunosuppressive agent with high activity in organs and bone marrow transplantation, could be expected to prove effective in this disease owing to its action on lymphocytes. Seven patients with bullous pemphigoid were treated with CyA in daily doses of 6 to 8 mg/kg bodyweight. Treatment was monitored by measurements of serum CyA, creatinine and liver enzyme levels. The effectiveness of treatment was assessed on clinical changes. The seven cases are dealt with individually, with a brief case-report for each of them. The only side-effects observed were reversible rises in serum creatinine levels and hypertrichosis in two cases; these are usual reactions to the drug. Hormonal assays were normal in two female patients. Concerning results, our patients fell into two groups. Among those treated with CyA alone there were two failures and two sustained satisfactory results. Treatment was successful in all patients treated with CyA during relapses under corticosteroid therapy, but two patients relapsed after CyA was discontinued. It is concluded that CyA is of no interest in the acute phase of bullous pemphigoid, that the long-term stability of the results obtained is doubtful and that this potentially nephrotoxic drug should be avoided or administered with extreme caution in elderly people, since their renal function may be at the limit of normality.

摘要

大疱性类天疱疮是一种典型的自身免疫性疾病。传统上,其治疗方法是单独使用全身性皮质类固醇或与免疫抑制剂联合使用。环孢素A(CyA)是一种在器官和骨髓移植中具有高活性的新型免疫抑制剂,由于其对淋巴细胞的作用,有望在这种疾病中证明有效。7例大疱性类天疱疮患者接受了CyA治疗,日剂量为6至8mg/kg体重。通过测量血清CyA、肌酐和肝酶水平来监测治疗情况。根据临床变化评估治疗效果。对这7例病例分别进行处理,每个病例都有简短的病例报告。观察到的唯一副作用是血清肌酐水平可逆性升高以及2例出现多毛症;这些是该药物的常见反应。2例女性患者的激素检测结果正常。关于治疗结果,我们的患者分为两组。在仅接受CyA治疗的患者中,有2例治疗失败,2例持续取得满意效果。在皮质类固醇治疗复发期间接受CyA治疗的所有患者治疗均成功,但2例患者在停用CyA后复发。得出的结论是,CyA在大疱性类天疱疮急性期无应用价值,所获结果的长期稳定性值得怀疑,并且这种具有潜在肾毒性的药物在老年人中应避免使用或极其谨慎地使用,因为他们的肾功能可能已接近正常极限。

相似文献

1
[Cyclosporin in the treatment of bullous pemphigoid: preliminary study].[环孢素治疗大疱性类天疱疮:初步研究]
Ann Dermatol Venereol. 1986;113(4):309-13.
2
The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report.四环素和烟酰胺治疗大疱性类天疱疮。初步报告。
Arch Dermatol. 1986 Jun;122(6):670-4.
3
High-dose methylprednisolone in the treatment of bullous pemphigoid.大剂量甲泼尼龙治疗大疱性类天疱疮。
Arch Dermatol. 1984 Sep;120(9):1157-65.
4
[Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].[接受外用糖皮质激素治疗的大疱性类天疱疮患者的皮肤感染]
Ann Dermatol Venereol. 2010 May;137(5):345-51. doi: 10.1016/j.annder.2010.03.015. Epub 2010 Apr 18.
5
[Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study].
Ann Dermatol Venereol. 1984;111(10):925-8.
6
[Therapy of pemphigus and pemphigoid].[天疱疮和类天疱疮的治疗]
Z Hautkr. 1986 Jun 1;61(11):811-2.
7
[Successful treatment of autoimmune bullous diseases with a combination therapy of ciclosporin and corticosteroid].环孢素与皮质类固醇联合治疗自身免疫性大疱性疾病的成功案例
Nihon Hifuka Gakkai Zasshi. 1989 Jan;99(1):53-7.
8
Long term plasma exchange therapy in bullous pemphigoid.大疱性类天疱疮的长期血浆置换疗法
Acta Derm Venereol. 1986;66(1):73-5.
9
[Therapy of bullous pemphigoid with erythromycin].[用红霉素治疗大疱性类天疱疮]
Med Klin (Munich). 1990 Aug 15;85(8):481-4.
10
[One year follow-up of patients with bullous pemphigoid].大疱性类天疱疮患者的一年随访
Ann Dermatol Venereol. 2009 May;136(5):407-11. doi: 10.1016/j.annder.2009.01.009. Epub 2009 Apr 23.

引用本文的文献

1
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.大疱性类天疱疮治疗的进展:全面的药物研发管线更新。
Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29.
2
Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review.大疱性类天疱疮和天疱疮患者中糖皮质激素节约剂的副作用:一项系统评价。
JAAD Int. 2022 Aug 7;9:33-43. doi: 10.1016/j.jdin.2022.07.005. eCollection 2022 Dec.
3
[Bullous pemphigoid: a new look at a well-known disease].
[大疱性类天疱疮:对一种知名疾病的新认识]
Hautarzt. 2014 Dec;65(12):1013-6. doi: 10.1007/s00105-014-3538-0.
4
Bullous pemphigoid: from bench to bedside.大疱性类天疱疮:从实验台到病床边
Drugs. 2005;65(7):905-26. doi: 10.2165/00003495-200565070-00002.
5
Management of autoimmune skin disorders in the elderly.老年人自身免疫性皮肤病的管理
Drugs Aging. 2004;21(12):767-77. doi: 10.2165/00002512-200421120-00002.